Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesEBIATMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Repurchased
Ratios

Fennec Pharmaceuticals (FENC) Long-Term Debt Issuances: 2012-2022

  • Fennec Pharmaceuticals' Long-Term Debt Issuances was N/A to -$65,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $26.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2023, which is 79.96% down from last year.
  • According to the latest figures from Q4 2022, Fennec Pharmaceuticals' Long-Term Debt Issuances is -$65,000, which was down 100.33% from $20.0 million recorded in Q3 2022.
  • Fennec Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $20.0 million during Q3 2022, with a 5-year trough of -$65,000 in Q4 2022.
  • For the 1-year period, Fennec Pharmaceuticals' Long-Term Debt Issuances averaged around $10.0 million, with its median value being $10.0 million (2022).